[Cytokines in surgery for pulmonary tuberculosis]

Area of Science:

• Thoracic surgery
• Immunology
• Pulmonary medicine

Background:

• Pulmonary tuberculosis (TB) treatment often requires surgical intervention.
• Thoracoplasty is a surgical procedure used to treat TB, but its effects on local immune responses are not fully understood.
• Understanding cytokine production post-thoracoplasty is crucial for optimizing patient recovery and managing inflammation.

Purpose of the Study:

• To compare the local cytokine production after traditional thoracoplasty versus thoracoplasty augmented with a polypropylene mesh.
• To evaluate the impact of different thoracoplasty methods on the inflammatory microenvironment in TB patients.

Main Methods:

• A comparative study involving patients undergoing traditional thoracoplasty and those receiving polypropylene mesh (Surgipro - SPMM-149) endoprosthesis.
• Measurement of tumor necrosis factor-alpha (TNF-α) and interleukin-10 (IL-10) in surgical exudate using solid-phase enzyme immunoassay.
• Analysis of local cytokine balance and inflammatory markers.

Main Results:

• Thoracoplasty with polypropylene mesh resulted in more pronounced local production of both pro-inflammatory (TNF-α) and anti-inflammatory (IL-10) cytokines.
• The cytokine balance shifted more significantly towards inflammation following mesh implantation.
• The observed inflammatory response was independent of the degree of drug sensitivity in the tuberculosis patients.

Conclusions:

• Polypropylene mesh augmentation in thoracoplasty for TB leads to a heightened local inflammatory response.
• The use of mesh implants influences the cytokine milieu, potentially impacting healing and recovery.
• Further research is warranted to explore the clinical implications of this enhanced inflammation.